EDEN PRAIRIE, Minn., March 26, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving ...
EDEN PRAIRIE, Minn., April 09, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving ...
CLEVELAND – Trigeminal neuralgia (TN) is a debilitating, chronic syndrome that causes sudden, severe, electric shock-like pain in the face. While TN isn’t life-threatening, it can severely alter ...
EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care ...
6don MSN
NeuroOne targets at least $10.5M revenue in 2026 while advancing brain and pain therapy platforms
NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Management View Dave Rosa, President, CEO & Director, stated the company is projecting fiscal year 2026 sales to be "at least $10.5 million, ...
NeuroOne Medical Technologies Corporation announced that CEO Dave Rosa participated in an interview on Today’s Marketplace, discussing advancements in epilepsy treatment alongside Dr. Jessica Clark ...
NeuroOne Medical Technologies Corporation NMTC recently received FDA 510(k) clearance for its OneRF Trigeminal Nerve Ablation System, a minimally invasive solution for treating severe facial pain. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results